Fleishman-Hillard overhauls MedEd function following Kate Hawker's exit

Fleishman-Hillard is merging its medical education practice The Remedy into its healthcare PR division, following the departure of two senior directors.

Kate Hawker: launches Medea Communications
Kate Hawker: launches Medea Communications

The Remedy founder Kate Hawker has left to set up a new medical comms shop with Charlotte Florence, a fellow director at the med ed practice.

The new venture will be called Medea Communications and will operate as a boutique agency within healthcare comms company InforMed Direct.

F-H’s PR and med ed teams will now be fully integrated and will operate under the title of Fleishman-Hillard Healthcare. The Remedy name will cease to exist as part of the plans.

The F-H healthcare team will continue to include med ed specialists and it is looking to expand the business with new recruits. The team will be overseen by F-H director and partner, head of healthcare PR Lorna Baxter.

‘F-H continues to provide a full service offering to its healthcare clients, through an integrated team of 40 healthcare specialists that spans PR, med ed, public affairs, consumer health and digital comms,’ said Baxter. ‘To bring our PR and med ed teams even closer together, I will now be overseeing the
broader healthcare team,’ she added.

F-H has already sought to bolster its med ed offering with the appointment of Marilyn Ewan as an account director in its healthcare team. She will focus on F-H’s medical comms work and joins the agency from her role as a manager at Datapharm Communications.

The Remedy was set up by Hawker in 2000 and was bought by F-H in 2005. Hawker previously worked as an associate director at MediTech Media and at a number of healthcare PR agencies including Shire Hall.

Florence joined The Remedy in 2001 and briefly left to work as an associate director at Burson-Marsteller for 18 months before rejoining The Remedy. She also previously worked for ten years in medical sales, clinical development and medical affairs at pharma firm GlaxoSmithKline.

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury finishes sixth day of deliberations

Max Clifford trial jury finishes sixth day of deliberations

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home and will reconvene tomorrow morning for a seventh day of deliberations.

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Analysis: Fishburn chiefs keep eyes on future despite mounting departures

Fishburn's management have defended their reinvention of the 23-year-old agency amid industry mutterings, fed by a series of director-level departures, about the direction in which it is going.

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

Hit or Miss? EasyJet backs Shakespeare Day campaign with world record attempt

EasyJet aimed to break the world record for the highest ever theatrical performance for Shakespeare's 450th birthday yesterday with the Reduced Shakespeare Company performing on a flight from Gatwick to Verona.

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Top PRs to gather in Barcelona for inaugural PRWeek Global Congress

Senior executives from IBM, Nestlé, Vedanta, GE, Cargill, Philips and Allianz will be among the speakers at PRWeek's first Global Congress.